The many facets of liquid biopsies in lymphoma.
作者信息
Kurtz David M
机构信息
Stanford University.
出版信息
Blood. 2022 Mar 24;139(12):1780-1781. doi: 10.1182/blood.2021015022.
Abstract
摘要
相似文献
1
The many facets of liquid biopsies in lymphoma.
Blood. 2022 Mar 24;139(12):1780-1781. doi: 10.1182/blood.2021015022.
2
Liquid biopsy in lymphoma.
Haematologica. 2019 Apr;104(4):648-652. doi: 10.3324/haematol.2018.206177. Epub 2019 Mar 7.
3
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities.
Crit Rev Oncol Hematol. 2018 Jul;127:56-65. doi: 10.1016/j.critrevonc.2018.05.010. Epub 2018 May 17.
4
MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma.
Br J Haematol. 2019 Jun;185(5):974-977. doi: 10.1111/bjh.15674. Epub 2018 Nov 8.
5
Liquid biopsies of plasma and cerebrospinal fluid are useful for detection of intravascular lymphoma with central nervous system symptoms alone.
Ann Hematol. 2022 Mar;101(3):709-711. doi: 10.1007/s00277-021-04572-2. Epub 2021 Jul 3.
6
Core needle biopsies and surgical excision biopsies in the diagnosis of lymphoma-experience at the Lymph Node Registry Kiel.
Ann Hematol. 2016 Aug;95(8):1281-6. doi: 10.1007/s00277-016-2704-0. Epub 2016 May 28.
7
Utility of gastric brushing in the diagnosis of malignant lymphoma.
Acta Cytol. 1994 Mar-Apr;38(2):169-74.
8
The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA.
Hematol Oncol. 2020 Feb;38(1):34-37. doi: 10.1002/hon.2704. Epub 2019 Dec 30.
9
Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas.
Semin Hematol. 2023 Jul;60(3):132-141. doi: 10.1053/j.seminhematol.2023.06.006. Epub 2023 Jun 30.
10
Comment on skin biopsies for diagnosing intravascular lymphoma: A retrospective study of diagnostic accuracy.
J Am Acad Dermatol. 2023 Jan;88(1):e47-e48. doi: 10.1016/j.jaad.2021.03.127. Epub 2021 Jul 24.
引用本文的文献
1
Early assessment of therapeutic efficacy in lymphoma patients via a blood-based multi-omics response monitoring test.
BMC Cancer. 2025 Jul 1;25(1):1078. doi: 10.1186/s12885-025-14457-6.
2
Elective splenectomy for hematological diseases: a vanishing indication.
Surg Endosc. 2024 Nov;38(11):6332-6337. doi: 10.1007/s00464-024-11071-8. Epub 2024 Aug 29.
3
Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.
Cancers (Basel). 2024 Jan 11;16(2):321. doi: 10.3390/cancers16020321.
4
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research.
Leukemia. 2022 Sep;36(9):2151-2164. doi: 10.1038/s41375-022-01618-w. Epub 2022 Jun 14.
本文引用的文献
1
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma.
Blood. 2022 Mar 24;139(12):1863-1877. doi: 10.1182/blood.2021012852.
2
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma.
J Clin Oncol. 2021 Aug 10;39(23):2605-2616. doi: 10.1200/JCO.20.02573. Epub 2021 Apr 28.
3
Sensitive tumour detection and classification using plasma cell-free DNA methylomes.
Nature. 2018 Nov;563(7732):579-583. doi: 10.1038/s41586-018-0703-0. Epub 2018 Nov 14.
4
Enhanced detection of circulating tumor DNA by fragment size analysis.
Sci Transl Med. 2018 Nov 7;10(466). doi: 10.1126/scitranslmed.aat4921.
5
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.
J Clin Oncol. 2018 Oct 1;36(28):2845-2853. doi: 10.1200/JCO.2018.78.5246. Epub 2018 Aug 20.
6
Diffuse large B-cell lymphoma genotyping on the liquid biopsy.
Blood. 2017 Apr 6;129(14):1947-1957. doi: 10.1182/blood-2016-05-719641. Epub 2017 Jan 17.
7
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.
Sci Transl Med. 2016 Nov 9;8(364):364ra155. doi: 10.1126/scitranslmed.aai8545.
8
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin.
Cell. 2016 Jan 14;164(1-2):57-68. doi: 10.1016/j.cell.2015.11.050.
9
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.
Blood. 2015 Jun 11;125(24):3679-87. doi: 10.1182/blood-2015-03-635169. Epub 2015 Apr 17.
10
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study.
Lancet Oncol. 2015 May;16(5):541-9. doi: 10.1016/S1470-2045(15)70106-3. Epub 2015 Apr 1.
Zotero 插件